Virpax Pharmaceuticals, Inc.
Market Cap
$13.67K
P/E Ratio
—
EPS
$-71.00
Dividend Yield
0.00%
52-Week Range
$0.00 — $11.75
Volume
300
Avg Volume
2.08K
Beta
2.01
P/E (TTM)
—
Forward P/E
—
PEG Ratio
-0.00
P/S (TTM)
0.00
P/B (TTM)
-0.05
P/FCF
—
EV/EBITDA
—
EV/Sales
—
ROE (TTM)
3.64%
ROA (TTM)
-3.47%
ROIC
—
Gross Margin
0.00%
Operating Margin
0.00%
Net Margin
—
Debt/Equity
0.00
Current Ratio
0.63
EPS Growth (YoY)
—
Revenue Growth (YoY)
—
EPS Growth (3Y)
-72.72%
EPS Growth (5Y)
-43.74%
Sales Growth (3Y)
+0.00%
Sales Growth (5Y)
+0.00%
EPS Est (This Year)
$-12.50
EPS Est (Next Year)
$-13.25
Dividend Yield
—
Annual Dividend
—
Payout Ratio
—
Frequency
—
Ex-Dividend Date
—
Cash/Share
$0.36
Institutional %
—
Inst. Net Change
—
Insider Net Shares (90d)
—
Outstanding Shares
1.24M
Float
1.05M
Free Float %
84.76%
Sector
Healthcare
Industry
Biotechnology
Country
US
Exchange
NASDAQ
IPO Date
2021-02-17
Employees
2
CEO
Jatinder Dhaliwal
Index Membership
—
Website
https://www.virpaxpharma.com
Virpax Pharmaceuticals, Inc. (VRPX) is a healthcare company in the biotechnology industry listed on the NASDAQ. With a market capitalization of $13.67K, VRPX is tracked by stockscreenr alongside 25,000+ other tickers. Use the free stock screener to compare VRPX against other stocks using dozens of fundamental and technical filters.
No, Virpax Pharmaceuticals, Inc. (VRPX) does not currently pay a regular dividend. The company may be reinvesting profits into growth, research, or debt reduction instead of returning cash to shareholders through dividends.
Virpax Pharmaceuticals, Inc. (VRPX) has a market capitalization of $13,668, classifying it as a micro-cap company. Market cap is calculated by multiplying the current share price by the total number of outstanding shares.